Issue link: http://osercommunicationsgroup.uberflip.com/i/858133
Chain Drugstore Daily Tuesday, August 22, 2017 4 2 2017 Best of Show PHARMACY TIMES RANKS NO. 1 AMONG PHARMACISTS IN AVERAGE PAGE EXPOSURES Pharmacy Times ® , a leading media resource for pharmacists and the pharma- cy industry, ranked the highest in ad vis- ibility among pharmacy journals for average page exposures, according to the results of the 2017 Kantar Media Pharmacy Readership study, which included 17 publications. Moreover, Pharmacy Times once again took top marks as the most-read pharmacy journal among retail chain pharmacists. Pharmacy Times also ranked No. 1 in average issue readership and average page exposures among younger pharma- cists practicing less than 10 years, mak- ing it the most-read pharmacy journal by practicing millennials and demonstrating the educational content value of every issue. The annual Kantar Media study measures the readership habits of thousands of pharmacists and pharma- cy professionals. Respondents include pharmacists working in chain and independent retail pharmacies and health-system pharmacies, as well as pharmacy professionals in key posi- tions at pharmacy benefit management companies and managed care organi- zations. The results, based on surveys completed from January to May 2017, show that Pharmacy Times outranked all competitors in average page expo- sures among the total sample studied. "Our No. 1 status year after year demonstrates the continued value our pharmacist audience reserves for our brand and the role Pharmacy Times serves as the industry's most trusted resource for more than 120 years," said Brian Haug, President of Pharmacy Healthcare & Communications LLC, a franchise of Michael J. Hennessy Associates Inc., which publishes Pharmacy Times. "It is because of the incredible talent and com- mitment of our editorial staff, sales team and produc- tion department that Pharmacy Times continues to deliver timely, accurate, practical and educational content that keeps step with the continuously evolv- ing pharmacy industry." Leadership Among Retail Pharmacists, Multiple Categories Pharmacy Times, which circulates to more than 173,000 retail pharmacists, ranked No. 1 in average page exposures and average issue readership among total independent, chain and health- system pharmacists. Specifically, Pharmacy Times ranked first in average page exposures among retail pharma- cists who fill 200 or more prescriptions per day, as well as among pharmacists who make 10 or more prescription rec- ommendations a day, making it the most-read pharmacy journal among that audience. Additionally, Pharmacy Times topped average issue readership and average page exposures among pharma- cists who use the Internet two or more times a day for pharmacy-related purposes, underscoring the publica- tion's continued value as a timely and accessible resource for the latest indus- try news and information regarding products, medication errors, drug inter- actions, patient education and counsel- ing, and disease state management. Moreover, Pharmacy Times is the most-read pharmacy journal among members of the American Pharmacists Association, for whom Pharmacy Times also ranked No. 1 in average issue read- ership and average page exposures. For more information, visit booth #2335 or contact John Hydrusko, Associate Director of Sales and Digital Media Strategy at 609.613.8996 or jhydrusko@pharmacytimes.com. PRASCO RELAUNCHES CORPORATE WEBSITE Since its inception in 2002, Prasco has been a leader in the category of Authorized Generics. An Authorized Generic (AG) is the brand prescription product sold in private label packaging at generic prices. It is identical to the brand in every way, meaning that an AG con- tains the exact same active and inactive ingredients as the brand. With the same shape, color, size, smell, taste and mouth feel, the patient receives an identical experience to the brand product. Because an AG competes as a gener- ic, the patient gets brand quality at lower prices. Prasco has helped save consumers billions of dollars by launching Authorized Generic versions of some of the most widely used medications, such as Zyprexa ® , Colcrys ® , Protonix ® , Cymbalta ® , Adderall XR ® and many oth- ers. Prasco's AGs increase generic com- petition, providing more treatment options to those who need high quality medications, at prices they can afford. To further tell the story, Prasco relaunched its corporate website earlier this year. Perhaps the most important component of Prasco.com is the focus on consumers – pharmacists, physicians and especially patients – who play an ever- increasing role in choosing and paying for medications. Because AGs are still a rela- tively new concept, helping consumers become more aware of their benefits is one of the website's primary goals. The new, user-friendly site offers: a clear definition of what an AG is – the brand prescription product sold in private label packaging at generic prices; visual demonstrations of how AGs are identical to the brand in every way and why that's beneficial; com- pelling data on the value of AGs – specif- ically, how they increase competition, offer more access to high-quality, afford- able medications, and provide billions of dollars in savings to patients and health- care providers; and a thor- ough product list that gives detailed information about Prasco products so physi- cians, pharmacists and patients can make informed decisions about using AGs when available. In addition to a con- sumer-focused message on Authorized Generics, Prasco's website also refers directly to its primary reasons for suc- cess: strong partnerships with the most trusted, innovative brand companies in the pharmaceutical industry, and strong relationships with customers across all pharmaceutical trade channels. For more information, visit booth #1013 or go to www.prasco.com.